{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:45:49Z","timestamp":1794300349662,"version":"4.9.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u8001\u5e74\u6ccc\u5c3f\u529f\u80fd\u4eba\u7fa4\u961f\u5217\u53ca\u6570\u636e\u5e73\u53f0\u5efa\u8bbe","award":["2020YFC3602901"],"award-info":[{"award-number":["2020YFC3602901"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42861-w","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:49:06Z","timestamp":1773204546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gamma-aminobutyric acid transaminase mediates tumor suppression in renal cell carcinoma through the cGAS-STING\u2013interferon-\u03b2 axis"],"prefix":"10.1038","volume":"16","author":[{"given":"Yi","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xupeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"42861_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.euf.2020.12.020","volume":"8","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. A global trend analysis of kidney cancer incidence and mortality and their associations with smoking, alcohol consumption, and metabolic syndrome. Eur. Urol. Focus 8, 200. https:\/\/doi.org\/10.1016\/j.euf.2020.12.020 (2022).","journal-title":"Eur. Urol. Focus"},{"key":"42861_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.trecan.2018.05.003","volume":"4","author":"D Lindgren","year":"2018","unstructured":"Lindgren, D., Sj\u00f6lund, J. & Axelson, H. Tracing renal cell carcinomas back to the nephron. Trends Cancer 4, 472. https:\/\/doi.org\/10.1016\/j.trecan.2018.05.003 (2018).","journal-title":"Trends Cancer"},{"key":"42861_CR3","doi-asserted-by":"publisher","first-page":"g4797","DOI":"10.1136\/bmj.g4797","volume":"349","author":"E Jonasch","year":"2014","unstructured":"Jonasch, E., Gao, J. & Rathmell, W. K. Renal cell carcinoma. BMJ 349, g4797. https:\/\/doi.org\/10.1136\/bmj.g4797 (2014).","journal-title":"BMJ"},{"key":"42861_CR4","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","volume":"14","author":"F Chen","year":"2016","unstructured":"Chen, F. et al. Multilevel genomics-based taxonomy of renal cell carcinoma. Cell Rep. 14, 2476. https:\/\/doi.org\/10.1016\/j.celrep.2016.02.024 (2016).","journal-title":"Cell Rep."},{"key":"42861_CR5","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Primers 3, 17009. https:\/\/doi.org\/10.1038\/nrdp.2017.9 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"42861_CR6","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.2147\/cmar.S240869","volume":"12","author":"Y He","year":"2020","unstructured":"He, Y. et al. Perioperative circulating tumor DNA in colorectal liver metastases: Concordance with metastatic tissue and predictive value for tumor burden and prognosis. Cancer Manag Res 12, 1621. https:\/\/doi.org\/10.2147\/cmar.S240869 (2020).","journal-title":"Cancer Manag Res"},{"key":"42861_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA Cancer J. Clin. 65, 5. https:\/\/doi.org\/10.3322\/caac.21254 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"42861_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","volume":"599","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. B cell-derived GABA elicits IL-10(+) macrophages to limit anti-tumour immunity. Nature 599, 471. https:\/\/doi.org\/10.1038\/s41586-021-04082-1 (2021).","journal-title":"Nature"},{"key":"42861_CR9","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1158\/2159-8290.Cd-23-0389","volume":"13","author":"M Tagore","year":"2023","unstructured":"Tagore, M. et al. GABA regulates electrical activity and tumor initiation in melanoma. Cancer Discov. 13, 2270. https:\/\/doi.org\/10.1158\/2159-8290.Cd-23-0389 (2023).","journal-title":"Cancer Discov."},{"key":"42861_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13046-025-03315-9","volume":"44","author":"M Xie","year":"2025","unstructured":"Xie, M. et al. GABA regulates metabolic reprogramming to mediate the development of brain metastasis in non-small cell lung cancer. J. Exp. Clin. Cancer Res. 44, 61. https:\/\/doi.org\/10.1186\/s13046-025-03315-9 (2025).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"42861_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang, D. et al. Cancer-cell-derived GABA promotes \u03b2-catenin-mediated tumour growth and immunosuppression. Nat. Cell Biol. 24, 230. https:\/\/doi.org\/10.1038\/s41556-021-00820-9 (2022).","journal-title":"Nat. Cell Biol."},{"key":"42861_CR12","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18712","volume":"12","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. Insights and progress on the biosynthesis, metabolism, and physiological functions of gamma-aminobutyric acid (GABA): A review. PeerJ 12, e18712. https:\/\/doi.org\/10.7717\/peerj.18712 (2024).","journal-title":"PeerJ"},{"key":"42861_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02268-1","volume":"18","author":"J Lu","year":"2020","unstructured":"Lu, J. et al. ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma. J. Transl. Med. 18, 101. https:\/\/doi.org\/10.1186\/s12967-020-02268-1 (2020).","journal-title":"J. Transl. Med."},{"key":"42861_CR14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1603269113","volume":"113","author":"B Zhao","year":"2016","unstructured":"Zhao, B. et al. Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins. Proc. Natl. Acad. Sci. U. S. A. 113, E3403. https:\/\/doi.org\/10.1073\/pnas.1603269113 (2016).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"42861_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1158\/0008-5472.Can-23-2049","volume":"84","author":"Q Zhuang","year":"2024","unstructured":"Zhuang, Q. et al. RNA methyltransferase FTSJ3 regulates the Type I Interferon Pathway to promote hepatocellular carcinoma immune evasion. Cancer Res. 84, 405. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-2049 (2024).","journal-title":"Cancer Res."},{"key":"42861_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","volume":"559","author":"SM Haag","year":"2018","unstructured":"Haag, S. M. et al. Targeting STING with covalent small-molecule inhibitors. Nature 559, 269. https:\/\/doi.org\/10.1038\/s41586-018-0287-8 (2018).","journal-title":"Nature"},{"key":"42861_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/acschembio.9b00810","volume":"15","author":"DC Rawling","year":"2020","unstructured":"Rawling, D. C. et al. Small-molecule antagonists of the RIG-I innate immune receptor. ACS Chem. Biol. 15, 311. https:\/\/doi.org\/10.1021\/acschembio.9b00810 (2020).","journal-title":"ACS Chem. Biol."},{"key":"42861_CR18","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/2159-8290.Cd-23-0669","volume":"13","author":"LD Engstrom","year":"2023","unstructured":"Engstrom, L. D. et al. MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP-deleted cancer. Cancer Discov. 13, 2412. https:\/\/doi.org\/10.1158\/2159-8290.Cd-23-0669 (2023).","journal-title":"Cancer Discov."},{"key":"42861_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ccell.2020.12.010","volume":"39","author":"P Kalev","year":"2021","unstructured":"Kalev, P. et al. MAT2A inhibition blocks the growth of MTAP-deleted cancer cells by reducing PRMT5-dependent mRNA splicing and inducing DNA damage. Cancer Cell 39, 209. https:\/\/doi.org\/10.1016\/j.ccell.2020.12.010 (2021).","journal-title":"Cancer Cell"},{"key":"42861_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/embor.2008.45","volume":"9","author":"M Lacroix","year":"2008","unstructured":"Lacroix, M. et al. The histone-binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5. EMBO Rep. 9, 452. https:\/\/doi.org\/10.1038\/embor.2008.45 (2008).","journal-title":"EMBO Rep."},{"key":"42861_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2001936","volume":"4","author":"P Andreu-P\u00e9rez","year":"2011","unstructured":"Andreu-P\u00e9rez, P. et al. Protein arginine methyltransferase 5 regulates ERK1\/2 signal transduction amplitude and cell fate through CRAF. Sci. Signal. 4, ra58. https:\/\/doi.org\/10.1126\/scisignal.2001936 (2011).","journal-title":"Sci. Signal."},{"key":"42861_CR22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.148486","volume":"286","author":"G Guderian","year":"2011","unstructured":"Guderian, G. et al. RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity. J. Biol. Chem. 286, 1976. https:\/\/doi.org\/10.1074\/jbc.M110.148486 (2011).","journal-title":"J. Biol. Chem."},{"key":"42861_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.02.017","volume":"1863","author":"AW El-Hattab","year":"2017","unstructured":"El-Hattab, A. W., Craigen, W. J. & Scaglia, F. Mitochondrial DNA maintenance defects. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 1539. https:\/\/doi.org\/10.1016\/j.bbadis.2017.02.017 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"42861_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01419-6","volume":"26","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic mitochondrial DNA. Nat. Cell Biol. 26, 878. https:\/\/doi.org\/10.1038\/s41556-024-01419-6 (2024).","journal-title":"Nat. Cell Biol."},{"key":"42861_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2022.08.059","volume":"32","author":"Q Lyu","year":"2022","unstructured":"Lyu, Q. et al. A small proportion of X-linked genes contribute to X chromosome upregulation in early embryos via BRD4-mediated transcriptional activation. Curr. Biol. 32, 4397. https:\/\/doi.org\/10.1016\/j.cub.2022.08.059 (2022).","journal-title":"Curr. Biol."},{"key":"42861_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/17588359211034708","volume":"13","author":"DJ George","year":"2021","unstructured":"George, D. J., Lee, C. H. & Heng, D. New approaches to first-line treatment of advanced renal cell carcinoma. Ther. Adv. Med. Oncol. 13, 17588359211034708. https:\/\/doi.org\/10.1177\/17588359211034708 (2021).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"42861_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006890","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis. J. Immunother. Cancer. https:\/\/doi.org\/10.1136\/jitc-2023-006890 (2023).","journal-title":"J. Immunother. Cancer."},{"key":"42861_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02674-x","volume":"42","author":"A Liu","year":"2023","unstructured":"Liu, A. et al. PRMT5 methylating SMAD4 activates TGF-\u03b2 signaling and promotes colorectal cancer metastasis. Oncogene 42, 1572. https:\/\/doi.org\/10.1038\/s41388-023-02674-x (2023).","journal-title":"Oncogene"},{"key":"42861_CR29","doi-asserted-by":"publisher","DOI":"10.7150\/thno.59605","volume":"11","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y. et al. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression. Theranostics 11, 9162. https:\/\/doi.org\/10.7150\/thno.59605 (2021).","journal-title":"Theranostics"},{"key":"42861_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/jci175023","author":"W Yan","year":"2024","unstructured":"Yan, W. et al. PRMT5-mediated FUBP1 methylation accelerates prostate cancer progression. J. Clin. Invest. https:\/\/doi.org\/10.1172\/jci175023 (2024).","journal-title":"J. Clin. Invest."},{"key":"42861_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.031","volume":"59","author":"M Frau","year":"2013","unstructured":"Frau, M., Feo, F. & Pascale, R. M. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. J. Hepatol. 59, 830. https:\/\/doi.org\/10.1016\/j.jhep.2013.04.031 (2013).","journal-title":"J. Hepatol."},{"key":"42861_CR32","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-24-0887","volume":"15","author":"B Belmontes","year":"2025","unstructured":"Belmontes, B. et al. AMG 193, a clinical stage MTA-cooperative PRMT5 inhibitor, drives antitumor activity preclinically and in patients with MTAP-deleted cancers. Cancer Discov. 15, 139. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-0887 (2025).","journal-title":"Cancer Discov."},{"key":"42861_CR33","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-25-1507","volume":"85","author":"K Drizyte-Miller","year":"2025","unstructured":"Drizyte-Miller, K. et al. Combination of the MTA-cooperative PRMT5 inhibitor BMS-986504 and KRAS inhibitors is an effective treatment strategy for MTAP-deleted KRAS-mutant pancreatic cancer. Cancer Res. 85, 3540. https:\/\/doi.org\/10.1158\/0008-5472.Can-25-1507 (2025).","journal-title":"Cancer Res."},{"key":"42861_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2339","volume":"35","author":"J Rodon","year":"2024","unstructured":"Rodon, J. et al. First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: Results from phase I dose exploration. Ann. Oncol. 35, 1138. https:\/\/doi.org\/10.1016\/j.annonc.2024.08.2339 (2024).","journal-title":"Ann. Oncol."},{"key":"42861_CR35","doi-asserted-by":"publisher","DOI":"10.1042\/cs20200680","volume":"134","author":"C Zhang","year":"2020","unstructured":"Zhang, C. & Zhuang, S. The role of protein arginine methyltransferases in kidney diseases. Clin. Sci. 134, 2037. https:\/\/doi.org\/10.1042\/cs20200680 (2020).","journal-title":"Clin. Sci."},{"key":"42861_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051111","author":"P Che","year":"2021","unstructured":"Che, P. et al. Integrin \u03b1v\u03b23 engagement regulates glucose metabolism and migration through focal adhesion kinase (FAK) and protein arginine methyltransferase 5 (PRMT5) in glioblastoma cells. Cancers https:\/\/doi.org\/10.3390\/cancers13051111 (2021).","journal-title":"Cancers"},{"key":"42861_CR37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.002377","volume":"293","author":"L Huang","year":"2018","unstructured":"Huang, L. et al. Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis. J. Biol. Chem. 293, 10884. https:\/\/doi.org\/10.1074\/jbc.RA118.002377 (2018).","journal-title":"J. Biol. Chem."},{"key":"42861_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1092-z","volume":"17","author":"Y \u015eenbabao\u011flu","year":"2016","unstructured":"\u015eenbabao\u011flu, Y. et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 17, 231. https:\/\/doi.org\/10.1186\/s13059-016-1092-z (2016).","journal-title":"Genome Biol."},{"key":"42861_CR39","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-06-2599","volume":"13","author":"RH Thompson","year":"2007","unstructured":"Thompson, R. H. et al. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin. Cancer Res. 13, 1757. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-2599 (2007).","journal-title":"Clin. Cancer Res."},{"key":"42861_CR40","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.00868","volume":"40","author":"WK Rathmell","year":"2022","unstructured":"Rathmell, W. K. et al. Management of metastatic clear cell renal cell carcinoma: ASCO guideline. J. Clin. Oncol. 40, 2957. https:\/\/doi.org\/10.1200\/jco.22.00868 (2022).","journal-title":"J. Clin. Oncol."},{"key":"42861_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102299","volume":"6","author":"D Stupichev","year":"2025","unstructured":"Stupichev, D. et al. AI-driven multimodal algorithm predicts immunotherapy and targeted therapy outcomes in clear cell renal cell carcinoma. Cell Rep. Med. 6, 102299. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102299 (2025).","journal-title":"Cell Rep. Med."},{"key":"42861_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejca.2019.04.003","volume":"114","author":"AY Shah","year":"2019","unstructured":"Shah, A. Y. et al. Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors. Eur. J. Cancer. 114, 67. https:\/\/doi.org\/10.1016\/j.ejca.2019.04.003 (2019).","journal-title":"Eur. J. Cancer."},{"key":"42861_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116547","volume":"44","author":"M Li","year":"2025","unstructured":"Li, M. et al. ID1 boosts antiviral immunity by countering PRMT5-mediated STING methylation. Cell Rep. 44, 116547. https:\/\/doi.org\/10.1016\/j.celrep.2025.116547 (2025).","journal-title":"Cell Rep."},{"key":"42861_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.trsl.2025.05.007","volume":"281","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. Epigenetically targeting PRMT5 promotes antitumor immunity by inducing endogenous retroviruses expression and triggering viral mimicry response. Transl. Res. 281, 55. https:\/\/doi.org\/10.1016\/j.trsl.2025.05.007 (2025).","journal-title":"Transl. Res."},{"key":"42861_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz5683","author":"H Kim","year":"2020","unstructured":"Kim, H. et al. PRMT5 control of cGAS\/STING and NLRC5 pathways defines melanoma response to antitumor immunity. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaz5683 (2020).","journal-title":"Sci. Transl. Med."},{"key":"42861_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110415","volume":"27","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. Decoding sunitinib resistance in ccRCC: Metabolic-reprogramming-induced ABAT and GABAergic system shifts. iScience 27, 110415. https:\/\/doi.org\/10.1016\/j.isci.2024.110415 (2024).","journal-title":"iScience"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42861-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:13:48Z","timestamp":1776813228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42861-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42861"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42861-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Renal tissue samples were acquired from the Kidney Biobank of the Department of Urology at the Chinese PLA General Hospital during the period spanning January to December 2019. The study protocol involving human specimens received ethical approval from the Chinese PLA General Hospital Ethics Committee (Approval No. S2013-065-01).\n                      Confirming\n                      The study is reported in accordance with ARRIVE guidelines. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13082"}}